Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential Expression of Proteins in an Atypical Presentation of Autoimmune Lymphoproliferative Syndrome. | Int J Mol Sci | 2022 | 35628184 | PubTator, text mining | PubMed |
| Construction of a ceRNA Network and Comprehensive Analysis of lncRNA in Hepatocellular Carcinoma. | Genes (Basel) | 2022 | 35627170 | PubTator, text mining | PubMed |
| Three-Dimensional Organotypic Cultures Reshape the microRNAs Transcriptional Program in Breast Cancer Cells. | Cancers (Basel) | 2022 | 35626094 | PubTator, text mining | PubMed |
| Transcription Factor NRF2 Participates in Cell Cycle Progression at the Level of G1/S and Mitotic Checkpoints. | Antioxidants (Basel) | 2022 | 35624810 | PubTator, text mining | PubMed |
| YY1 affects the levels and function of fibulin-5 in ox-LDL-treated vascular smooth muscle cells. | Exp Ther Med | 2022 | 35619637 | PubTator, text mining | PubMed |
| Targeting aberrant replication and DNA repair events for treating breast cancers. | Commun Biol | 2022 | 35610507 | PubTator, text mining | PubMed |
| Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer. | Biomed Res Int | 2022 | 35601155 | PubTator, text mining | PubMed |
| Using Weighted Gene Co-Expression Network Analysis to Identify Increased MND1 Expression as a Predictor of Poor Breast Cancer Survival. | Int J Gen Med | 2022 | 35601002 | PubTator, text mining | PubMed |
| SEMA6D Differentially Regulates Proliferation, Migration, and Invasion of Breast Cell Lines. | ACS Omega | 2022 | 35571788 | PubTator, text mining | PubMed |
| Study of tRNA-Derived Fragment tRF-20-S998LO9D in Pan-Cancer. | Dis Markers | 2022 | 35571614 | PubTator, text mining | PubMed |
| Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer. | Front Genet | 2022 | 35559045 | PubTator, text mining | PubMed |
| Small Molecule Inhibitor Targeting CDT1/Geminin Protein Complex Promotes DNA Damage and Cell Death in Cancer Cells. | Front Pharmacol | 2022 | 35548337 | PubTator, text mining | PubMed |
| Degron masking outlines degronons, co-degrading functional modules in the proteome. | Commun Biol | 2022 | 35545699 | PubTator, text mining | PubMed |
| Human cytomegalovirus RNA2.7 inhibits RNA polymerase II (Pol II) Serine-2 phosphorylation by reducing the interaction between Pol II and phosphorylated cyclin-dependent kinase 9 (pCDK9). | Virol Sin | 2022 | 35537980 | PubTator, text mining | PubMed |
| Identification of a seven-cell cycle signature predicting overall survival for gastric cancer. | Aging (Albany NY) | 2022 | 35537781 | PubTator, text mining | PubMed |
| The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors. | Cell Mol Life Sci | 2022 | 35532818 | PubTator, text mining | PubMed |
| A ceRNA Network Composed of Survival-Related lncRNAs, miRNAs, and mRNAs in Clear Cell Renal Carcinoma. | Comput Math Methods Med | 2022 | 35529267 | PubTator, text mining | PubMed |
| Discovery of Anticancer Activity of Amentoflavone on Esophageal Squamous Cell Carcinoma: Bioinformatics, Structure-Based Virtual Screening, and Biological Evaluation. | J Microbiol Biotechnol | 2022 | 35484963 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts in breast cancer: Challenges and opportunities. | Cancer Commun (Lond) | 2022 | 35481621 | PubTator, text mining | PubMed |
| Esophageal squamous cell carcinoma: Integrated bioinformatics analysis for differential gene expression with identification of hub genes and lncRNA. | Biochem Biophys Rep | 2022 | 35479061 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=30